Gavi’s CEO Dr Seth Berkley presents an overview of the Alliance’s achievements to the Board on 2 December 2015. Topics include a summary of results and challenges in the 2011-2015 strategy period, Gavi’s increasing focus on coverage, equity and sustainability going forward, global health security and the broader immunisation landscape.
Gavi’s CEO Dr Seth Berkley presents an overview of the Vaccine Alliance’s achievements to the Board on 22 June 2016. Topics include results and challenges in the 2011-2015 period, early progress in implementing the 2016-2020 strategy and the role of immunisation on the global agenda.
Dr Seth Berkley presents a general update to the Gavi Board meeting in Côte d’Ivoire, reporting on previous Board decisions, global health threats and how the Alliance is gearing up to deliver on the new strategy.
Dr Seth Berkley presents a general update to the Gavi Board meeting in Geneva, reporting on key developments in the global landscape, previous Board decisions, strategic discussion topics and critical findings from partner and performance reviews of the Alliance.
First presented at the Meningitis Vaccine Project Closure Conference in Addis Ababa in February, Gavi’s CEO Seth Berkley gives a summary of Gavi’s role in reducing the burden of meningitis in Africa.
New presentation on immunisation in the Asia-Pacific region, including support to pentavalent, pneumococcal, measles, rubella, HPV, Japanese encephalitis, hepatitis B and inactivated polio vaccines, the growing number of manufacturers of Gavi-supported vaccines based in Asia-Pacific, and the increasing co-financing contributions by countries in the region. Despite great progress challenges remain: almost half of the world’s under-immunised children are in Gavi-supported countries in Asia-Pacific.
Gavi CEO Seth Berkley presents key achievements and challenges to the Gavi Board on 10 June 2015. Topics covered include: successful replenishment, new vaccine introductions, coverage and equity, sustainability, the broader immunisation landscape and risk management.
Gavi’s CEO Dr Seth Berkley presents an overview of the Vaccine Alliance’s achievements to the Board on 22 June 2016. Topics include results and challenges in the 2011-2015 period, early progress in implementing the 2016-2020 strategy and the role of immunisation on the global agenda.
Dr Seth Berkley presents a general update to the Gavi Board meeting in Côte d’Ivoire, reporting on previous Board decisions, global health threats and how the Alliance is gearing up to deliver on the new strategy.
Dr Seth Berkley presents a general update to the Gavi Board meeting in Geneva, reporting on key developments in the global landscape, previous Board decisions, strategic discussion topics and critical findings from partner and performance reviews of the Alliance.
First presented at the Meningitis Vaccine Project Closure Conference in Addis Ababa in February, Gavi’s CEO Seth Berkley gives a summary of Gavi’s role in reducing the burden of meningitis in Africa.
New presentation on immunisation in the Asia-Pacific region, including support to pentavalent, pneumococcal, measles, rubella, HPV, Japanese encephalitis, hepatitis B and inactivated polio vaccines, the growing number of manufacturers of Gavi-supported vaccines based in Asia-Pacific, and the increasing co-financing contributions by countries in the region. Despite great progress challenges remain: almost half of the world’s under-immunised children are in Gavi-supported countries in Asia-Pacific.
Gavi CEO Seth Berkley presents key achievements and challenges to the Gavi Board on 10 June 2015. Topics covered include: successful replenishment, new vaccine introductions, coverage and equity, sustainability, the broader immunisation landscape and risk management.
Dr Seth Berkley presents an update to the Gavi Board meeting in Geneva, Switzerland, covering key developments in the global landscape, strategic progress, previous Board decisions and updates from the Alliance.
Dr Seth Berkley presents an update to the Gavi Board meeting in New Delhi, India, covering key developments in the global landscape; how Gavi is working differently to reach zero-dose communities and strengthen primary health care; previous Board decisions; and updates from the Alliance and the Secretariat.
The 5-in-1 pentavalent vaccine is now available in all Gavi-supported countries at a record low price, but only 50% of the children are being reached. Learn more about the pentavalent success story – and the challenges that remain.
Presentation from Gavi CEO Dr Seth Berkley during the replenishment launch at the Seventh Tokyo International Conference on African Development (TICAD) in Yokohama, co-hosted by the Japanese government.
From 10–11 December, the global health community and leaders are meeting in Abu Dhabi to review progress midway through Gavi’s 2016–2020 investment period.
MTR session: This is now…18 years of progress
Dr Berkley reflects on two topics:
- Gavi’s progress vis-à-vis its 2016-2020 promises
- Existing and future Gavi challenges as well as lessons learned.
PLEASE NOTE: THESE SLIDES MAY NOT DISPLAY PROPERLY ONLINE, BUT THEY ARE READABLE IF DOWNLOADED.
October 28, 2018
This one-day conference explored the current pharmaceutical pricing landscape by bringing together leaders from the pharmaceutical industry, policymakers, legal practitioners, and scholars to engage in novel, interdisciplinary discussions to better understand current challenges and articulate best practices to address these issues. Participants assessed the current challenges presented in drug pricing policy, from development to delivery, in both the United States and international context. We also explored and articulated best practices to expand access to medicines and worked toward developing a plan for disseminating these practices more widely.
Immunisation in a digital world - Futures WorkshopILC- UK
On Tuesday, 26th June the International Longevity Centre - UK (ILC-UK) hosted a one-day Futures Workshop on immunisation in a digital world in Brussels.
The workshop hosted medical professionals, communications experts, policy makers and technological innovators to discuss how new technologies can help to improve adult immunisation and the barriers to implementation and uptake.
For more information visit http://www.ilcuk.org.uk/index.php/events/immunisation_in_a_digital_world_futures_workshop
Dr Seth Berkley presents an update to the Gavi Board meeting in Geneva, Switzerland, covering key developments in the global landscape, strategic progress, previous Board decisions and updates from the Alliance.
Dr Seth Berkley presents an update to the Gavi Board meeting in New Delhi, India, covering key developments in the global landscape; how Gavi is working differently to reach zero-dose communities and strengthen primary health care; previous Board decisions; and updates from the Alliance and the Secretariat.
The 5-in-1 pentavalent vaccine is now available in all Gavi-supported countries at a record low price, but only 50% of the children are being reached. Learn more about the pentavalent success story – and the challenges that remain.
Presentation from Gavi CEO Dr Seth Berkley during the replenishment launch at the Seventh Tokyo International Conference on African Development (TICAD) in Yokohama, co-hosted by the Japanese government.
From 10–11 December, the global health community and leaders are meeting in Abu Dhabi to review progress midway through Gavi’s 2016–2020 investment period.
MTR session: This is now…18 years of progress
Dr Berkley reflects on two topics:
- Gavi’s progress vis-à-vis its 2016-2020 promises
- Existing and future Gavi challenges as well as lessons learned.
PLEASE NOTE: THESE SLIDES MAY NOT DISPLAY PROPERLY ONLINE, BUT THEY ARE READABLE IF DOWNLOADED.
October 28, 2018
This one-day conference explored the current pharmaceutical pricing landscape by bringing together leaders from the pharmaceutical industry, policymakers, legal practitioners, and scholars to engage in novel, interdisciplinary discussions to better understand current challenges and articulate best practices to address these issues. Participants assessed the current challenges presented in drug pricing policy, from development to delivery, in both the United States and international context. We also explored and articulated best practices to expand access to medicines and worked toward developing a plan for disseminating these practices more widely.
Immunisation in a digital world - Futures WorkshopILC- UK
On Tuesday, 26th June the International Longevity Centre - UK (ILC-UK) hosted a one-day Futures Workshop on immunisation in a digital world in Brussels.
The workshop hosted medical professionals, communications experts, policy makers and technological innovators to discuss how new technologies can help to improve adult immunisation and the barriers to implementation and uptake.
For more information visit http://www.ilcuk.org.uk/index.php/events/immunisation_in_a_digital_world_futures_workshop
Progress, Challenges and Opportunities for Vaccines to Reduce Under-5 Childho...Sara Berlanda
In this slideset, Professor Shabir Madhi, WAidid board member, analyses the trends in global and sub-Saharan Africa under-5 childhood mortality, to then demonstrate the contribution of new childhood vaccines in reducing under-5/neonatal morbidity and mortality by vaccination.
To learn more, visit www.waidid.org!
The Power of Vaccines: ‘getting to zero’ for HIV and TB was an event hosted by the TB/HIV and Prevention Working Groups of the UK Consortium on AIDS and International Development. The meeting was sponsored by Pamela Nash MP and held on Friday, 18th May 2012, in Portcullis House, Westminster. Read more at http://storify.com/PamojaUK/the-power-of-vaccines
http://www.pamoja.uk.com
ILC webinar: Under the microscope: Comparing countries’ experiences of the CO...ILC- UK
COVID-19 has had devastating effects on health systems and economies across the world and has put the importance of the prevention of ill health throughout the life course into sharp focus– from the importance of better pandemic preparedness to the need to promote the overall health of the population.
This ILC webinar is part of our “Delivering prevention in an ageing world” programme.
The panellists presented their country perspectives on how each of their countries have responded to COVID-19 and what we can learn from the pandemic for the prevention agenda going forward.
The PPT gives overview of PEI, global updates on PEI, Polio end game strategy and eradication timelines, polio legacy and link with Health Systems strengthening and relevant health programes etc. The PPT was presented at National Annual Review Meeting held for 2 days in Mussoorie for Core Group of Polio Project (CGPP) -a USAID funded polio eradication initiatives. ADRA India is one of the lead implementing agency for CGPP since 2004 and it has worked for nearly 15 years in polio across states in India.
AIDSTAR-One Increasing Access to Prevention of Mother-to-Child Transmission S...AIDSTAROne
This technical report discusses the many services needed throughout the prevention of mother-to-child transmission (PMTCT) and infant care services continuum and identifies potential barriers to service coverage, access, and utilization. AIDSTAR-One provides examples of evidence-based and emerging practices to mitigate these barriers.
www.aidstar-one.com/focus_areas/pmtct/resources/report/increasing_access_to_pmtct_services
Dr Seth Berkley presents an update to the Gavi Board meeting in Geneva, Switzerland, covering key developments in the global landscape, strategic progress, previous Board decisions and updates from the Alliance.
Data presentation on global trends in immunisation, health and development. The presentation included a summary of the issues Gavi was created to address and how the results of its work are manifested in different countries.
Dr Seth Berkley presents an update to the Gavi Board meeting in Geneva, Switzerland, reporting on key developments in the global landscape, strategic progress, previous Board decisions and updates from the Alliance.
Gavi CEO Dr Seth Berkley presents an update to the Gavi Board meeting in Vientiane, Lao PDR, reporting on key developments in the global landscape, previous Board decisions and strategic discussion topics.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
3. Board meeting
2-3 December 2015
UN Sustainable Development Summit, Sep 2015
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
4. Board meeting
2-3 December 2015
From MDGs 4, 5 and 6 to new global health goal
Ensure healthy lives and promote well-being for all at all ages
• Target 3.2: ...end preventable deaths of … children under 5 years
• Target 3.8: Achieve UHC … access to quality essential health-care
services and to safe, effective, quality and affordable essential
medicines and vaccines for all
• Target 3b: Support the research and development of vaccines
….provide access to affordable essential medicines and vaccines…
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
5. Board meeting
2-3 December 2015
Gavi proposes vaccine indicator
• Based on the Global Vaccine Action Plan:
“Reach and sustain 90% national coverage and 80% in every
district with all vaccines in national programmes”
• Decision expected: March 2016
The Board was shocked
to learn that the perhaps
single most relevant
indicator in the health
sector, immunisation
coverage, is not currently
being considered as an
individual item in the SDG
monitoring framework.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
6. Board meeting
2-3 December 2015
12.7
MDG4: Reduce child mortality by two-thirds
1990 2015
5.9
MDG4
target4.2
Number of
children dying
under 5 years
old (millions)
17.5
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
7. Board meeting
2-3 December 2015
Gavi recognised as successful financing model:
“We will support relevant initiatives, such as Gavi, the Vaccine
Alliance....
“...existing mechanisms, such as the International Finance Facility
for Immunisation, might be replicated to address broader
development needs.”
Financing the Global Goals:
Addis Ababa Action Agenda, July 2015
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
8. Board meeting
2-3 December 2015
Sources: More than 4 million refugees in 2014, Jornal de Notícias; UNHCR Global Trends 2014
Diseases
know no
borders
Migration:
top 10 destinations for refugees
Developing regions host 86% of world’s refugees
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
9. Board meeting
2-3 December 2015
Ebola: focus on global health security
• Five global reviews on global
health preparedness
• Vaccines an important part of
the discussion: “An
international vaccine
development fund is urgently
needed [to] avert a repetition
of the Ebola crisis.”
7 Nov
Sierra Leone declared Ebola free
End Nov
Three new cases in Liberia
Today
Guinea, 4 weeks to go
Liberia
declared
Ebola free
Liberia
declared
Ebola free
Sierra
Leone
declared
Ebola free
Extracted from “CDC's Response to Ebola” 2014-2015, updated with WHO data until Nov 2015.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
10. Board meeting
2-3 December 2015
Less than 1/3 of the world is prepared to respond
to outbreaks
By 2012 deadline, < 20% of countries met core capacity
requirements under WHO International Health Regulations
Source: Report to the Director-General
of the Review Committee on Second
Extensions for Establishing National
Public Health Capacities and on IHR
Implementation, November 2014
By 2014, this
had only increased
to 30%
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Only 13/73 Gavi
countries have achieved
75% of requirements for
preparedness, response,
surveillance and labs
11. Board meeting
2-3 December 2015
Continued resurgence of measles
Data in WHO HQ as of 9 November 2015
US: big outbreak -
first measles death in
12 years, July
Australia: outbreak in
Aug-Sept
China: ~ 40,000 cases
Jan-Sept
DR Congo: ~ 20,000
cases Jan-Sept
0(49 countries or 25%)
1 - 9(29 countries or 15%)
10 - 99(45 countries or 23%)
100 - 999(30 countries or 15%)
≥1000(10 countries or 5%)
No data reported to WHO HQ(31 countries or 16%)
Not applicable
Number of cases
Number of reported measles cases with onset date from Apr 2015 to Sep 2015
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
12. Board meeting
2-3 December 2015
Boost routine immunisation
to eliminate measles
• Coverage: DTP3 has increased but measles flat-lining
• Routine immunisation: only half of children get 2nd dose
measles vaccine through routine system
• Coordination: need more cohesive approach with routine
immunisation at the core
Coverage in Gavi-supported countries
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Source: WHO/UNICEF Estimates of National
Immunization Coverage, 2015.
13. Board meeting
2-3 December 2015
Looking back:
Wild poliovirus cases May-October 2011
Endemic country
Wild virus type 1
Country with
importation case
Wild virus type 3
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Data in WHO HQ as
of 31 October 2011
14. Board meeting
2-3 December 2015
1 Excludes viruses detected from
environmental surveillance
2 Onset of paralysis 18 May – 17
November 2015
Data in WHO HQ as
of 17 November 2015
Wild poliovirus cases1, May-November 20152
Nigeria no longer
polio endemic
Africa on its way to
becoming polio-free
Endemic country
Wild poliovirus type 1
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
15. Board meeting
2-3 December 2015
cVDPV type 1
cVDPV type 2
1 Excludes viruses detected from
environmental surveillance.
2 Onset of paralysis 18 May – 17
November 2015
cVDPV cases1, May-November 20152
Endemic country
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Data in WHO HQ as
of 17 November 2015
16. Board meeting
2-3 December 2015
Number of Gavi-supported countries that have introduced IPV
IPV introduction delays but SAGE still
recommends April switch to bivalent OPV
Objective set by
Board in Nov 2013
Actual/projected country
introductions of IPV
Current status:
34 introductions
Target set in
Nov 2013
SwitchtOPV/bOPV
~ 19 countries
to introduce
after the switch
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
17. Board meeting
2-3 December 2015
How polio resources can help
strengthen routine immunisation
• People: experienced public health workers, social mobilisers, volunteers
• Outreach: have access to hard-to-reach households
• Planning: maps and micro-plans to reach neglected communities
• Data and surveillance: monitoring and analysis, real-time global
surveillance, GIS and response capacity
Gavi: proposed way forward
• No capacity/mandate to take over partners’ human resource networks
• Country-driven, country-specific approach
• Integrated in national programmes
• Focus on equitable and sustainable immunisation coverage
• Health system strengthening and Partners’ Engagement Framework key
instruments for support
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
19. Board meeting
2-3 December 2015
Board Chair-elect: Ngozi Okonjo-Iweala
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
20. Board meeting
2-3 December 2015
New contribution from the Republic of Korea
“Health and children are a priority for Korea’s development cooperation
policy and Gavi is our partner.”
Lee Yongsoo, Director-General Development Cooperation
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
21. Board meeting
2-3 December 2015
A more diverse financial base
Donor pledges
London, 2011
Donor pledges
Berlin, 2015
Other
2%
9 donors
29%
US$ 1.25 bn
3 donors
69%
US$ 4.345
billion
Other
3%
9 donors
43%
US$ 3.25 bn 3 donors
54%
US$ 7.539
billion
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
22. Board meeting
2-3 December 2015
2002 2004 2006 2008 2010 2012 2014 2016 2018 2020
Germany
Examples of donor growth
0
1,000
800
600
400
200
European
Commission
Republic
of Korea
Cumulativecontributions(US$millions)
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
23. Board meeting
2-3 December 2015
Visiting Ethiopia with DFID and the Global Fund,
July 2015
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
24. Board meeting
2-3 December 2015
Fifth award for IFFIm Sukuk, October 2015
Islamic Finance
Deal of the Year
Global Finance Magazine
Previous Sukuk awards:
• Financial Times’ Achievement in International Finance Award
• Islamic Finance News’ Social Impact Deal of the Year 2014
• EMEA Finance’s Best Supranational Sukuk
• Euromoney’s Innovation in Islamic Finance
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
25. Board meeting
2-3 December 2015
Vaccine introductions
Afghanistan: inactivated polio vaccine
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
26. Board meeting
2-3 December 2015
Vaccine introductions
Pakistan: inactivated polio vaccine
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
27. Board meeting
2-3 December 2015
Vaccine introductions
Papua New Guinea:
measles-rubella vaccine + IPV
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
28. Board meeting
2-3 December 2015
Nigeria (Northern states):
measles vaccine campaign
Vaccine introductions
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
29. Board meeting
2-3 December 2015
Vaccine introductions
Uganda: HPV national
introduction
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
30. Board meeting
2-3 December 2015
Vaccine introductions
Eritrea: pneumococcal vaccine
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
31. Board meeting
2-3 December 2015
Vaccine-type invasive pneumococcal disease
incidence in children under 2, the Gambia
Before and after pneumococcal vaccine introduction (PCV13)
0
50
100
150
200
250
Before PCV13
(2008-2010)
After PCV13
(2013-2014)
Incidenceper100,000population
82%
Reduction
Mackenzie GA et al. Impact of the Introduction of Pneumococcal Conjugate Vaccination on Invasive Pneumococcal
Disease in The Gambia: Population-Based Surveillance. Lancet Infectious Diseases, under review.
Note - other age groups available: 2-4 years, 5-14 years, >15 years; also: PCV7 type only, PCV 13 type only,
NVT, and all-type. Data here (PCV13 type , under 2) show highest impact.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
32. Board meeting
2-3 December 2015
Hospital admissions for diarrhoea before and
after rotavirus vaccine introduction, Rwanda
Ngabo F et al. Effect of pentavalent rotavirus vaccine introduction on hospital admissions for
diarrhea and rotavirus in children in Rwanda: a time-series analysis. Lancet Global Health, in press.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
33. Board meeting
2-3 December 2015
Vaccine stockpiles
Cameroon: first Gavi-funded
doses from OCV stockpile
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
34. Board meeting
2-3 December 2015
Vaccine stockpiles
Niger: meningitis A,C,Y,W
conjugate vaccine stockpile
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
36. Board meeting
2-3 December 2015
Mission indicators
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
37. Board meeting
2-3 December 2015
Vaccine goal indicators: country introductions
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
38. Board meeting
2-3 December 2015
15
28
57
Vaccine goal indicators: coverage
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
39. Board meeting
2-3 December 2015
Health systems goal indicators
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
40. Board meeting
2-3 December 2015
All key performance indicators available online
www.gavi.org/results/goal-level-indicators/
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
41. Board meeting
2-3 December 2015
First four countries transitioning from Gavi
support, 31 December 2015
Honduras
Sri Lanka
Bhutan
Mongolia
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
43. Board meeting
2-3 December 2015
Our main tasks 2016-2020
Maintain momentum of vaccine introductions
Increase coverage and equity
Strengthen routine immunisation
Ensure sustainability
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
44. Board meeting
2-3 December 2015
Finish the job: continued focus on vaccine
introductions
2011 2012 2013 2014 2015
>220 introductions
20162017 2018 2019 2020
>220 introductions
Sources: Vaccine Implementation data as of 15 September 2015. Unconstrained introduction dates used
for all vaccines except yellow fever and rotavirus vaccines.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
45. Board meeting
2-3 December 2015
Immunisation coverage in 73 Gavi-supported
countries
Coverage with three doses of DTP-containing vaccine
Source: WHO/UNICEF Estimates of National Immunization Coverage, 2015.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
46. Board meeting
2-3 December 2015
A closer look
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
47. Board meeting
2-3 December 2015
100%
Measles-containing vaccine
1st dose
Pentavalent vaccine
Measles-containing vaccine
2nd dose
Yellow fever vaccinea
Pneumococcal vaccine
Rotavirus vaccine
Rubella vaccine
HPV vaccineb
Coverage by vaccine (%)
Immunisation coverage in Gavi-supported countries
Coverage refers to the final dose of each vaccine, unless otherwise stated.
a Target population and coverage estimates are based on 32 yellow fever-endemic Gavi-supported countries in Africa.
b Target population for HPV is 10 year old girls.
Source: Gavi strategic demand forecast version 12.
70
77
45
83
86
56
80
51
21
20
2
72
48
53
39
79
by 2015 by 2020
Projections
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
48. Board meeting
2-3 December 2015
17 countries
13 countries
4 countries
14 countries
11 countries
12 countries
< 50% 50-59% 60-69% 70-79% 80-89% > 90%
Routine immunisation coverage has
increased rapidly in many Gavi countries
1999 2004 2009 2014
Routine immunisation coverage
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
49. Board meeting
2-3 December 2015
8 countries
5 countries
13 countries
15 countries 15 countries
16 countries
< 50% 50-59% 60-69% 70-79% 80-89% > 90%
Routine immunisation coverage has
increased rapidly in many Gavi countries
1999 2004 2009 2014
Routine immunisation coverage
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
50. Board meeting
2-3 December 2015
3 countries
2 countries
6 countries
16 countries
17 countries
28 countries
< 50% 50-59% 60-69% 70-79% 80-89% > 90%
Routine immunisation coverage has
increased rapidly in many Gavi countries
1999 2004 2009 2014
Routine immunisation coverage
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
51. Board meeting
2-3 December 2015
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
< 50% 50-59% 60-69% 70-79% 80-89% > 90%
5 countries
2 countries
4 countries
14 countries
16 countries
32 countries
Routine immunisation coverage has
increased rapidly in many Gavi countries
1999 2004 2009 2014
Routine immunisation coverage
52. Board meeting
2-3 December 2015
< 50% 50-59% 60-69% 70-79% 80-89% > 90%
“Ceiling effect” as coverage increases
Routine immunisation coverage
20
15
10
5
0
25
Average%changein5yearperiod
Average percentage point change in five-year period by baseline
coverage level, third dose DTP-containing vaccine
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
53. Board meeting
2-3 December 2015
New country-focused approach to deliver on our
strategy, 2016-2020
Aligned,
integrated and
holistic package
of support for
countries
Partners’
Engagement
Framework
including
targeted country
assistance
Prioritisation:
intensified focus
on 20 countries
Cross-cutting
strategic focus
areas
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
54. Board meeting
2-3 December 2015
20 priority countries
Representing 75%
of under-immunised
children in Gavi
countries
10 countries
most under-immunised children
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
10 countries
high inequities1 or conflict
1 High inequity is
defined as >20%
coverage difference
between highest
and lowest wealth
quintile in DHS
surveys after 2010.
N/A
55. Board meeting
2-3 December 2015
Priority country: India
• Coverage: world’s largest number of under-immunised
children
• Equity: poorest states have similar income levels to poorest
Gavi-supported countries
• Catalytic partnership to launch pneumococcal, rotavirus,
rubella, human papillomavirus vaccines
“India’s rich experience in universal immunization and
particularly its experience this year with the Mission
Indradhanush could be shared with all countries.”
-- Narendra Modi, Indian Prime Minister
Mission Indradhanush: building on Gavi HSS grant to
mainstream polio resources into routine immunisation
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
56. Board meeting
2-3 December 2015
Gavi’s investment per child in the 15 Gavi-
eligible countries with the biggest birth cohorts
-
50
100
150
200
250
300
0 500,000 1,000,000 1,500,000 2,000,000 2,500,000 3,000,000 3,500,000 4,000,000 4,500,000
Children under-immunised with DTP3 in 2014
Gaviinvestmentperchild(US$)
India
Nigeria
Pakistan
Indonesia
Ethiopia
Congo, DR
Kenya
Afghanistan
Tanzania
Bangladesh
Angola
Sudan (the)
Uganda
Mozambique
Vietnam
57. Board meeting
2-3 December 2015
Priority country: Madagascar
Intensification of activities for coverage & equity
Supply chain
Human
resources
Service
delivery &
community
Data &
planning Financing
Rapid
deployment of
solar-drive
fridges in all
health centres
Increased staffing
in Centres de
Santé de Base
Health worker
training
Outreach and
micro-planning
Community
mobilisation
through health
workers
Increased
availability of
data collection
tools (registries,
vaccination
cards)
Redesigned data
flow
Advocating for
sufficient
financing
ISSUESSOLUTIONS
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
58. Board meeting
2-3 December 2015
Technical assistance
package
Application
guidelines
Technology guide for
decision makers
Advocacy and
communications
5-10 countries expected to apply in 2016 (NOT EXHAUSTIVE)
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Cold Chain Equipment Platform:
launch preparations
59. Board meeting
2-3 December 2015
Vaccine-
preventable disease
surveillance
Proposed approach to data: what the
Alliance aims to achieve by 2020
Goals for
2020
Focus
areas
Strengthen country
surveillance systems &
create networks
Identify AEFI & investigate,
respond efficiently and
effectively and address
public concerns
Improve the availability,
quality, use of data &
strengthen health
workforce data use
capability
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Data for
Immunisation
Delivery, Coverage
& Equity (DCE)
Vaccine safety
60. Board meeting
2-3 December 2015
Sustainability: 21 countries in accelerated
transition phase
Countries in accelerated transition phase
Set to become fully self-financing
from 2016Note: Cuba and the Ukraine
are no longer receiving Gavi vaccine support.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
62. Board meeting
2-3 December 2015
Improving the way we work: examples
• Risk management: new organisational structure, dedicated risk
function, new Head of Risk
• Knowledge management: country portal facilitating communications
between countries and partners
• Simplification: eg revised programme funding policy
• Grant management: streamlining disbursement and review
processes
• Human resources: performance and talent management
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
63. Board meeting
2-3 December 2015
Streamlining Board documentation
June 2015:
608 pages + 9 additional
documents on myGavi
December 2015:
466 pages, no additional
documents on myGavi
myGavi: not just Board meeting
documents and presentations, but also:
• Up-to-date calendar of all Board and
Board Committee meetings
• Up-to-date list of all Board and Board
Committee members
• Statutes, by-laws and committee
charters
• Board member reference book
• Policy handbook
• Quarterly risk report and risk register
64. Board meeting
2-3 December 2015
Partners’ Engagement Framework in action:
Afghanistan
• Enhanced national capacity: 4 of 6 national officers moved from
partner offices to health ministry
• Stronger alignment: less duplication between partners, more
harmonised support
• More transparent: country has visibility on Gavi-funded support
(limited insight into partners’ submissions)
• More targeted: added support from new partner to build financial
management capacity (country priority)
• Increased value for money: 23% reduction in budget with reduced
spend on travel and consulting
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
65. Board meeting
2-3 December 2015
Strengthened grant management:
responding to Yemen crisis
• Tailoring support to countries
• Re-allocation: HSS funds
rapidly re-allocated to support
integrated outreach
• Result: 1,900 mobile teams
reached 70,000 children in
September
• Going forward: continued use
of funds for integrated outreach,
channelled through partners
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
66. Board meeting
2-3 December 2015
Gavi recognised for country engagement
A Snapshot of Development Partner Communication
and Performance (October 2015)
Based on interviews with 6,750 policymakers and practitioners in 126
low- and middle-income countries
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
67. Board meeting
2-3 December 2015
Eight areas of potential collaboration
between Gavi and the Global Fund
BIGGER PICTURE RECENT UPDATES 2011-2015 RESULTS 2016-2020: RAISING OUR GAME GEARING UP
Programmes
Risk management
Supply chain
Non-vaccine
procurement
Monitoring, evaluation
& data
Resource mobilisation
Communications &
advocacy
Headquarters
operations
68. Board meeting
2-3 December 2015
Growing business: More proactive management
of programmes & risk
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
247
590
2011 2015
Number of doses
per year
(USD millions)
2x2
3
1
4
6
12
2011 2015
Number of vaccines
supported
2x
68
372
2011 2015
Cash grants disbursement
per year
(USD millions)
5x
150
470
2011 2015
Number of active grants
(vaccines and cash)
3x
69. Board meeting
2-3 December 2015
Board retreat in Beijing, China, April 2016
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
• dd
70. Board meeting
2-3 December 2015
Adapting to the frictionless economy
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
71. Board meeting
2-3 December 2015
Adapting to the frictionless economy?
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP